Morgan Stanley analyst Emmet Kelly resumed coverage of Cellnex with an Equal Weight rating and EUR 44 price target. The company’s organic growth story is underappreciated, but its step back from expansionary acquisitions removes an opportunity to "turbo-charge" its bottom line, Kelly tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly